Molecular Diagnostics Market
Molecular Diagnostics Market Size, Share and Industry Analysis Report By Product & Service (Reagents, Kits and Instruments); By Test Type (Lab Tests and PoC Tests); By Technology (Polymerase Chain Reaction (PCR), Isothermal Nucleic Acid Amplification Technology (INAAT), DNA Sequencing & Next- generation Sequencing (NGS), In Situ Hybridization (ISH), DNA Microarrays and Others); By Application (Infectious diseases, Oncology, Genetic testing, Blood screening and Others); By End User (Diagnostic Labs, Hospitals and Others) - Forecast Year 2024 – 2031
Healthcare // Diagnostic Imaging
The global molecular
diagnostics market is foreseen to grow by 4.7%, from USD 21.63 Billion in 2021
to USD 31.23 Billion in 2029. Increasing prevalence of infectious diseases and
cancer, rising focus on R&D and growing funding in molecular diagnostics, growing
awareness of early disease diagnosis in developing countries, rising
technological advancements in molecular diagnostics is to drive the market for
the upcoming forecast period. However, unfavorable reimbursement scenario, high
cost of instruments remains one factor hindering the market growth over the
anticipated period.
Market Definition
What Is Molecular Diagnostics?
Market Overview
The
molecular diagnostics market search study helps to thoroughly understand
the current trend in the market competitive analysis of the players in the
emerging market. Moreover, the DRO in the molecular diagnostics market offers
valuable perspicuity and a current scenario for making the right decision. The
research study covers the eminent players in the market with a detailed
analysis of the company and a financial overview containing their net sales,
business mix and geographical reach It mainly focuses on the key developments
of the products/services offered by the company in recent years. Besides, we at
Zettabyte have the expertise to analyses the global Molecular diagnostics
market player's competitive landscape helping the client comprehend their
specific strategic growth approaches.
Molecular
diagnostics market study by "Zettabyte Analytics" offers details
about the market scope, market segmentation, technological advancement in the Molecular
diagnostics market and highlights the optimistic, competitive landscape and
trends enduring over the years.
Major players in
the Molecular diagnostics market include Abacus Diagnostica Oy, Abbott
Laboratories, Agilent Technologies, Inc., Amoy Diagnostics Co., Ltd., Becton,
Dickinson And Company, Biocartis Nv, Biomérieux Sa, Danaher Corporation,
Diasorin S.P.A., Elitechgroup, Exact Sciences Corporation, F. Hoffmann-La Roche
Ltd, Geneombio Technologies Pvt. Ltd., Genetic Signatures, Grifols, S.A.,
Hologic, Inc., Htg Molecular Diagnostics, Inc., Illumina, Inc., Mdxhealth,
Molbio Diagnostics Pvt. Ltd., Myriad Genetics, Inc., Perkinelmer, Inc., Qiagen
N.V., Quidel Corporation, Savyon Diagnostics, Siemens Healthineers Ag, Tbg
Diagnostics Limited, Thermo Fisher Scientific, Inc., Vela Diagnostics.
COVID-19 Impact on Global Molecular
Diagnostics Market
The global impact
of COVID-19 has lost millions of lives with a massive cost to the healthcare
system. Moreover, the treatment cost for patients with COVID-19 has also had a
financial impact globally. the impact of COVID-19 on the Molecular diagnostics
market has forced the companies to change their sourcing, pricing, and
promotion strategies. the molecular diagnostics market players are seen focusing
more on optimizing the e-commerce networks with the rising innovations in the
digital sector, which are creating new business models for the healthcare industry
player.
Research Scope
The report
provides market value for the base year 2021 and a yearly forecast from 2022 to
2029 in revenue (USD Million/ Billion). the market for each segment is present
in North America, Europe, Asia Pacific, Latin America, Middle East &
Africa, and the regional basis for the forecast mentioned above.
Key industry
dynamics, regulatory scenarios, major material dynamics and Molecular
diagnostics market future markets are analyzed to understand their impact on demand
for the forecast period. growth rates have been estimated using correlation,
regression and time-series analysis.
Market Segmentation
For the purpose
of this report, the global molecular diagnostics market segmented on the basis
of product & service, test type, technology, application, end user, and
region:
Product & Service Outlook:
On the basis of
product & service, the market is segmented into reagents & kits,
instruments, services & software.
Test Type Outlook:
On the basis of
Test Type, the market is segmented into Lab Tests, PoC Tests.
Technology Outlook:
On the basis of
Technology, the market is segmented into Polymerase Chain Reaction (PCR),
Isothermal Nucleic Acid Amplification Technology (INAAT), DNA Sequencing &
Next- generation Sequencing (NGS), In Situ Hybridization (ISH), DNA
Microarrays, Other Technologies.
Figure 1 Molecular diagnostics market By Technology
(Market Size And Forecast By Value - USD Million, 2021 & 2029)
Application Outlook:
On the basis of
application, the market is segmented into infectious disease diagnostics,
oncology testing, genetic testing, other applications. Further, infectious
disease diagnostics is segmented into covid-19, hepatitis, HIV, CT/NG, HAI, HPV,
tuberculosis, influenza, other infectious diseases. Further, oncology testing
is segmented into breast cancer, colorectal cancer, lung cancer, prostate
cancer, other cancers.
End User Outlook:
On the basis of
end user, the market is segmented into diagnostic laboratories, hospitals &
clinics, other end users.
Regional Outlook (Revenue, USD Million; 2021
& 2029)
|
Regional Outlook
(Revenue, USD Million; 2018-2029) |
|
|
North America |
U.S. |
|
Canada |
|
|
Europe |
Germany |
|
U.K. |
|
|
France |
|
|
Spain |
|
|
Italy |
|
|
Rest of the Europe |
|
|
Asia Pacific |
India |
|
Japan |
|
|
China |
|
|
South Korea |
|
|
Australia |
|
|
Rest of Asia-Pacific |
|
|
Middle East & Africa |
UAE |
|
Saudi Arabia |
|
|
South Africa |
|
|
Rest of Middle East & Africa |
|
|
Latin America |
Brazil |
|
Mexico |
|
|
Argentina |
|
|
Rest of Latin America |
|
Figure 2 Molecular Diagnostics
Market: Regional Dynamics
An exclusive molecular
diagnostics market research report provides an in-depth analysis of the market
dynamics across five regions: North America, Europe, South America,
Asia-Pacific, Middle East, and Africa. Furthermore, the market has been
evaluated by utilizing diverse research methodologies and internal statistical model.
Companies Considered And Profiled In This
Market Study
The players
operating in the market have undertaken several strategies related to the
market in the period 2019-2021. some of the prominent players in the molecular
diagnostics market include
· Abacus Diagnostica
Oy
· Abbott Laboratories
· Agilent
Technologies, Inc.
· Amoy Diagnostics
Co., Ltd.
· Becton, Dickinson
And Company
· Biocartis Nv
· Biomérieux Sa
· Danaher Corporation
· Diasorin S.P.A.
· Elitechgroup
· Exact Sciences
Corporation
· F. Hoffmann-La
Roche Ltd
· Geneombio
Technologies Pvt. Ltd.
· Genetic Signatures
· Grifols, S.A.
· Hologic, Inc.
· Htg Molecular
Diagnostics, Inc.
· Illumina, Inc.
· Mdxhealth
· Molbio Diagnostics
Pvt. Ltd.
· Myriad Genetics,
Inc.
· Perkinelmer, Inc.
· Qiagen N.V.
· Quidel Corporation
· Savyon Diagnostics
· Siemens
Healthineers Ag
· Tbg Diagnostics
Limited
· Thermo Fisher
Scientific, Inc.
· Vela Diagnostics
Global Molecular Diagnostics Market Report
Scope
|
Historical
data |
2018 - 2020 |
|
Base
year for estimation |
2021 |
|
Forecast
period |
2022 - 2029 |
|
Market
size value in 2022 |
USD XX Billion |
|
Revenue
forecast in 2029 |
USD 31.23 Billion |
|
Growth
Rate |
CAGR of 4.7%
from 2022 to 2029 |
|
Quantitative
units |
Revenue in USD Million/Billion & CAGR
from 2022 to 2029 |
|
Report
coverage |
Revenue
forecast, company share, competitive landscape, growth factors, and trends |
|
Segments
covered |
Product & Service, Test Type, Technology,
End User, Application |
|
Key
companies profiled |
F.
Hoffmann-La Roche Ltd, Hologic, Inc., Perkinelmer, Inc. |
|
Regional
Scope |
North America, Europe, Asia Pacific, Middle
East & Africa, Latin America |
|
Country
Scope |
U.S.,
Canada, Germany, U.K., France, Italy, Spain, India, Japan, China, Australia,
South Korea, Saudi Arabia, UAE, South Africa, Brazil, Mexico, Argentina |
|
Customization
scope |
Free report customization (equivalent to up
to 8 analysts’ working days) with purchase. Addition or alteration to
country, regional & segment scope. |
Product & Service Outlook (Revenue, USD
Million/Billion; 2018-2029)
· Reagents & Kits
· Instruments
· Services &
Software
Test Type Outlook (Revenue, USD
Million/Billion; 2018-2029)
· Lab Tests
· PoC Tests
Technology Outlook (Revenue, USD
Million/Billion; 2018-2029)
· Polymerase Chain
Reaction (PCR)
· Isothermal Nucleic
Acid Amplification Technology (INAAT)
· DNA Sequencing
& Next- generation Sequencing (NGS)
· In Situ
Hybridization (ISH)
· DNA Microarrays
· Other Technologies
Application Outlook (Revenue, USD
Million/Billion; 2018-2029)
· Infectious Disease
Diagnostics
o COVID-19
o Hepatitis
o HIV
o CT/NG
o HAI
o HPV
o Tuberculosis
o Influenza
o Other Infectious
Diseases
· Oncology Testing
o Breast Cancer
o Colorectal Cancer
o Lung Cancer
o Prostate Cancer
o Other Cancers
· Genetic Testing
· Other Applications
End User Outlook (Revenue, USD
Million/Billion; 2018-2029)
· Diagnostic
Laboratories
· Hospitals &
Clinics
· Other End Users
Regional Outlook (Revenue, USD
Million/Billion; 2018-2029)
· North America
o U.S.
o Canada
· Europe
o Germany
o U.K.
o France
o Spain
o Italy
o Rest of the Europe
· Asia Pacific
o India
o Japan
o China
o South Korea
o Australia
o Rest of
Asia-Pacific
· Middle East &
Africa
o UAE
o Saudi Arabia
o South Africa
o Rest of Middle East
& Africa
· Latin America
o Brazil
o Mexico
o Argentina
o Rest of Latin
America
Reasons to Buy the Report:
· Save and reduce
time carrying out entry-level research by identifying the growth, size, leading
players and segments in the global Molecular diagnostics market
· Highlights key
business priorities in order to guide the companies to reform their business strategies
and establish themselves in the wide geography.
· The key findings
and recommendations highlight crucial progressive industry trends in the Molecular
diagnostics market, thereby allowing players to develop effective long-term
strategies in order to garner their market revenue.
· Develop/modify
business expansion plans by using substantial growth offering developed and
emerging markets.
· Scrutinize in-depth
global market trends and outlook coupled with the factors driving the market,
as well as those restraining the growth at a certain extent.
· Enhance the
decision-making process by understanding the strategies that underpin
commercial interest with respect to products, segmentation and industry End
Users.
|
Chapter 1. Introduction |
|
|
1.1. Market Definition |
|
|
1.2. Research Scope |
|
|
1.2.1. Markets Covered |
|
|
1.2.2. Years Considered for
Study |
|
|
Chapter 2. Executive
Summary |
|
|
2.1. Summary Snapshot Market Size and
Forecast, 2018-2029 |
|
|
2.2. Molecular Diagnostics Market Share
by Product & Service, 2021 vs 2029 (USD Million) |
|
|
2.3. Molecular Diagnostics Market Share
by Test Type, 2021 vs 2029 (USD Million) |
|
|
2.4. Molecular Diagnostics Market Share
by Technology, 2021 vs 2029 (USD Million) |
|
|
2.5. Molecular Diagnostics Market Share
by Application, 2021 vs 2029 (USD Million) |
|
|
2.5. Molecular Diagnostics Market Share
by End User, 2021 vs 2029 (USD Million) |
|
|
2.6. Molecular Diagnostics Market Share
by Region, 2021 vs 2029 (USD Million) |
|
|
Chapter 3. Key Insights |
|
|
Chapter 4. Molecular
Diagnostics Market Segmentation & Impact Analysis |
|
|
4.1. Molecular Diagnostics Market
Indicators Analysis |
|
|
4.1.1. Market Drivers
Analysis |
|
|
4.1.1.1. Increasing
prevalence of infectious diseases and cancer |
|
|
4.1.1.2. Rising
focus on R&D and growing funding in molecular diagnostics |
|
|
4.1.1.3. Growing
awareness of early disease diagnosis in developing countries |
|
|
4.1.2. Market Restraint
Analysis |
|
|
4.1.2.1. Unfavorable
reimbursement scenario |
|
|
4.1.2.2. High cost
of instruments |
|
|
4.1.3. Market Opportunity
Analysis |
|
|
4.1.3.1. Growing
significance of companion diagnostics |
|
|
4.1.3.2. Growth opportunities
in emerging countries |
|
|
4.2. Regulatory Analysis |
|
|
4.2.1. North America |
|
|
4.2.1.1. U.S. |
|
|
4.2.1.2. Canada |
|
|
4.2.2. Europe |
|
|
4.2.3. Asia Pacific |
|
|
4.2.3.1. India |
|
|
4.2.3.2. Japan |
|
|
4.2.3.3. China |
|
|
4.3. Technological Insights |
|
|
4.4. COVID-19 Impact analysis on
Molecular Diagnostics Market |
|
|
4.5. Porter’s Five Forces Analysis |
|
|
4.5.1. Bargaining Power of
Buyers/Consumers |
|
|
4.5.2. Bargaining Power of
Suppliers |
|
|
4.5.3. Threat of New Entrants |
|
|
4.5.4. Threat of Substitute
Products |
|
|
4.5.5. Intensity of Competitive
Rivalry |
|
|
4.6. Competitive Metric Space Analysis |
|
|
Chapter 5. Molecular
Diagnostics Market, By Product & Service (Market Size and Forecast by
Value - USD Million, 2018 - 2029) |
|
|
5.1. Molecular Diagnostics Market, By
Product & Service (Market Size and Forecast by Value - USD Million, 2021
& 2029) |
|
|
5.1.1. Reagents & Kits |
|
|
5.1.1.1. Reagents & Kits Market Estimates and
Forecast, 2019-2029 (USD Million) |
|
|
5.1.1.2. Reagents & Kits Market Estimates and
Forecast, By Region, 2019-2029 (USD Million) |
|
|
5.1.2. Instruments |
|
|
5.1.2.1. Instruments
Market Estimates and Forecast, 2019-2029 (USD Million) |
|
|
5.1.2.2. Instruments Market Estimates
and Forecast, By Region, 2019-2029 (USD Million) |
|
|
5.1.3. Services & Software |
|
|
5.1.3.1. Services
& Software Market Estimates and Forecast, 2019-2029 (USD Million) |
|
|
5.1.3.2. Services &
Software Market Estimates and Forecast, By Region, 2019-2029 (USD Million) |
|
|
Chapter 6. Molecular
Diagnostics Market, By Test Type (Market Size and Forecast by Value - USD
Million, 2018 - 2029) |
|
|
6.1. Molecular Diagnostics Market, By Test
Type (Market Size and Forecast by Value - USD Million, 2021 & 2029) |
|
|
6.1.1. Lab Tests |
|
|
6.1.1.1. Lab Tests Market Estimates and Forecast,
2019-2029 (USD Million) |
|
|
6.1.1.2. Lab Tests Market Estimates and Forecast, By
Region, 2019-2029 (USD Million) |
|
|
6.1.2. PoC Tests |
|
|
6.1.2.1. PoC Tests Market Estimates and Forecast,
2019-2029 (USD Million) |
|
|
6.1.2.2. PoC Tests Market Estimates and Forecast,
By Region, 2019-2029 (USD Million) |
|
|
Chapter 7. Molecular
Diagnostics Market, By Technology (Market Size and Forecast by Value - USD
Million, 2017 - 2029) |
|
|
7.1. Molecular Diagnostics Market, By
Technology (Market Size and Forecast by Value - USD Million, 2021 & 2029) |
|
|
7.1.1. Polymerase Chain
Reaction (PCR) |
|
|
7.1.1.1. Polymerase Chain Reaction (PCR) Market
Estimates and Forecast, 2019-2029 (USD Million) |
|
|
7.1.1.2. Polymerase Chain Reaction (PCR) Market
Estimates and Forecast, By Region, 2019-2029 (USD Million) |
|
|
7.1.2. Isothermal Nucleic Acid
Amplification Technology (INAAT) |
|
|
7.1.2.1. Isothermal Nucleic Acid Amplification
Technology (INAAT) Market Estimates and Forecast, 2019-2029 (USD Million) |
|
|
7.1.2.2. Isothermal Nucleic Acid Amplification
Technology (INAAT) Market Estimates and Forecast, By Region, 2019-2029 (USD
Million) |
|
|
7.1.3. DNA Sequencing &
Next- generation Sequencing (NGS) |
|
|
7.1.3.1. DNA
Sequencing & Next- generation Sequencing (NGS) Market Estimates and
Forecast, 2019-2029 (USD Million) |
|
|
7.1.3.2. DNA
Sequencing & Next- generation Sequencing (NGS) Market Estimates and
Forecast, By Region, 2019-2029 (USD Million) |
|
|
7.1.4. In Situ Hybridization (ISH) |
|
|
7.1.4.1. In Situ
Hybridization (ISH) Market Estimates and Forecast, 2019-2029 (USD Million) |
|
|
7.1.4.2. In Situ
Hybridization (ISH) Market Estimates and Forecast, By Region, 2019-2029 (USD
Million) |
|
|
7.1.5. DNA Microarrays |
|
|
7.1.5.1. DNA Microarrays Market Estimates and
Forecast, 2019-2029 (USD Million) |
|
|
7.1.5.2. DNA Microarrays Market Estimates and Forecast,
By Region, 2019-2029 (USD Million) |
|
|
7.1.6. Other Technologies |
|
|
7.1.6.1. Other Technologies Market Estimates and
Forecast, 2019-2029 (USD Million) |
|
|
7.1.6.2. Other Technologies Market Estimates and
Forecast, By Region, 2019-2029 (USD Million) |
|
|
Chapter 8. Molecular
Diagnostics Market, By Application (Market Size and Forecast by Value - USD
Million, 2018 - 2028) |
|
|
8.1. Molecular Diagnostics Market, By Application
(Market Size and Forecast by Value - USD Million, 2021 & 2028) |
|
|
8.1.1. Infectious Disease
Diagnostics |
|
|
8.1.1.1. Infectious Disease Diagnostics Market
Estimates and Forecast, 2018-2028 (USD Million) |
|
|
8.1.1.2. Infectious Disease Diagnostics Market
Estimates and Forecast, By Region, 2018-2028 (USD Million) |
|
|
8.1.2. Oncology Testing |
|
|
8.1.2.1. Oncology Testing Market Estimates and
Forecast, 2018-2028 (USD Million) |
|
|
8.1.2.2. Oncology Testing Market Estimates and
Forecast, By Region, 2018-2028 (USD Million) |
|
|
8.1.3. Genetic Testing |
|
|
8.1.3.1. Genetic Testing Market Estimates
and Forecast, 2018-2028 (USD Million) |
|
|
8.1.3.2. Genetic
Testing Market Estimates and Forecast, By Region, 2018-2028 (USD Million) |
|
|
8.1.4. Other Applications |
|
|
8.1.4.1. Other Applications
Market Estimates and Forecast, 2018-2028 (USD Million) |
|
|
8.1.4.2. Other
Applications Market Estimates and Forecast, By Region, 2018-2028 (USD
Million) |
|
|
Chapter 9. Molecular
Diagnostics Market, By End User (Market Size and Forecast by Value - USD
Million, 2018 - 2029) |
|
|
9.1. Molecular Diagnostics Market, By
End User (Market Size and Forecast by Value - USD Million, 2021 & 2029) |
|
|
9.1.1. Diagnostic Laboratories |
|
|
9.1.1.1. Diagnostic Laboratories Market Estimates
and Forecast, 2019-2029 (USD Million) |
|
|
9.1.1.2. Diagnostic Laboratories Market Estimates
and Forecast, By Region, 2019-2029 (USD Million) |
|
|
9.1.2. Hospitals & Clinics |
|
|
9.1.2.1. Hospitals & Clinics Market Estimates
and Forecast, 2019-2029 (USD Million) |
|
|
9.1.2.2. Hospitals & Clinics Market Estimates and
Forecast, By Region, 2019-2029 (USD Million) |
|
|
9.1.3. Other End Users |
|
|
9.1.3.1. Other End
Users Market Estimates and Forecast, 2019-2029 (USD Million) |
|
|
9.1.3.2. Other End
Users Market Estimates and Forecast, By Region, 2019-2029 (USD Million) |
|
|
Chapter 10. Molecular
Diagnostics Market, By Region (Market Size and Forecast by Value - USD
Million, 2018 - 2029) |
|
|
10.1. Molecular Diagnostics Market, By
Region (Market Size and Forecast by Value - USD Million, 2021 & 2029) |
|
|
10.2. North America |
|
|
10.2.1. North America Molecular
Diagnostics Market, By Product & Service, 2018-2029 (USD Million) |
|
|
10.2.2. North America Molecular
Diagnostics Market, By Test Type, 2018-2029 (USD Million) |
|
|
10.2.3. North America Molecular
Diagnostics Market, By Technology, 2018-2029 (USD Million) |
|
|
10.2.4. North America Molecular
Diagnostics Market, By Application, 2018-2029 (USD Million) |
|
|
10.2.5. North America Molecular
Diagnostics Market, By End User, 2018-2029 (USD Million) |
|
|
10.2.6. North America Molecular
Diagnostics Market, By Country, 2018-2029 (USD Million) |
|
|
10.2.7. U.S. |
|
|
10.2.7.1. U.S.
Molecular Diagnostics Market, By Product & Service, 2018-2029 (USD
Million) |
|
|
10.2.7.2. U.S.
Molecular Diagnostics Market, By Test Type, 2018-2029 (USD Million) |
|
|
10.2.7.3. U.S.
Molecular Diagnostics Market, By Technology, 2018-2029 (USD Million) |
|
|
10.2.7.4. U.S. Molecular
Diagnostics Market, By Application, 2018-2029 (USD Million) |
|
|
10.2.7.5. U.S.
Molecular Diagnostics Market, By End User, 2018-2029 (USD Million) |
|
|
10.2.8. Canada |
|
|
10.2.8.1. Canada
Molecular Diagnostics Market, By Product & Service, 2017-2029 (USD
Million) |
|
|
10.2.8.2. Canada
Molecular Diagnostics Market, By Test Type, 2017-2029 (USD Million) |
|
|
10.2.8.3. Canada
Molecular Diagnostics Market, By Technology, 2017-2029 (USD Million) |
|
|
10.2.8.4. Canada
Molecular Diagnostics Market, By Application, 2017-2029 (USD Million) |
|
|
10.2.8.5. Canada
Molecular Diagnostics Market, By End User, 2017-2029 (USD Million) |
|
|
10.3. Europe |
|
|
10.3.1. Europe Molecular
Diagnostics Market, By Product & Service, 2018-2029 (USD Million) |
|
|
10.3.2. Europe Molecular Diagnostics
Market, By Test Type, 2018-2029 (USD Million) |
|
|
10.3.3. Europe Molecular
Diagnostics Market, By Technology, 2018-2029 (USD Million) |
|
|
10.3.4. EuropeMolecular
Diagnostics Market, By Application, 2018-2029 (USD Million) |
|
|
10.3.5. EuropeMolecular
Diagnostics Market, By End User, 2018-2029 (USD Million) |
|
|
10.3.6. Europe Molecular
Diagnostics Market, By Country, 2018-2029 (USD Million) |
|
|
10.3.7. Germany |
|
|
10.3.7.1. Germany Molecular Diagnostics
Market, By Product & Service, 2018-2029 (USD Million) |
|
|
10.3.7.2. Germany
Molecular Diagnostics Market, By Test Type, 2018-2029 (USD Million) |
|
|
10.3.7.3. Germany
Molecular Diagnostics Market, By Technology, 2018-2029 (USD Million) |
|
|
10.3.7.4. Germany
Molecular Diagnostics Market, By Application, 2018-2029 (USD Million) |
|
|
10.3.7.5. Germany
Molecular Diagnostics Market, By End User, 2018-2029 (USD Million) |
|
|
10.3.8. U.K. |
|
|
10.3.8.1. U.K.
Molecular Diagnostics Market, By Product & Service, 2017-2029 (USD
Million) |
|
|
10.3.8.2. U.K.
Molecular Diagnostics Market, By Test Type, 2017-2029 (USD Million) |
|
|
10.3.8.3. U.K.
Molecular Diagnostics Market, By Technology, 2017-2029 (USD Million) |
|
|
10.3.8.4. U.K.
Molecular Diagnostics Market, By Application, 2017-2029 (USD Million) |
|
|
10.3.8.5. U.K. Molecular
Diagnostics Market, By End User, 2017-2029 (USD Million) |
|
|
10.3.9. France |
|
|
10.3.9.1. France
Molecular Diagnostics Market, By Product & Service, 2019-2029 (USD
Million) |
|
|
10.3.9.2. France
Molecular Diagnostics Market, By Test Type, 2019-2029 (USD Million) |
|
|
10.3.9.3. France
Molecular Diagnostics Market, By Technology, 2019-2029 (USD Million) |
|
|
10.3.9.4. France
Molecular Diagnostics Market, By Application, 2019-2029 (USD Million) |
|
|
10.3.9.5. France
Molecular Diagnostics Market, By End User, 2019-2029 (USD Million) |
|
|
10.3.10. Spain |
|
|
10.3.10.1. Spain
Molecular Diagnostics Market, By Product & Service, 2018-2029 (USD
Million) |
|
|
10.3.10.2. Spain
Molecular Diagnostics Market, By Test Type, 2018-2029 (USD Million) |
|
|
10.3.10.3. Spain
Molecular Diagnostics Market, By Technology, 2018-2029 (USD Million) |
|
|
10.3.10.4. Spain
Molecular Diagnostics Market, By Application, 2018-2029 (USD Million) |
|
|
10.3.10.5. Spain
Molecular Diagnostics Market, By End User, 2018-2029 (USD Million) |
|
|
10.3.11. Italy |
|
|
10.3.11.1. Italy
Molecular Diagnostics Market, By Product & Service, 2018-2029 (USD
Million) |
|
|
10.3.11.2. Italy
Molecular Diagnostics Market, By Test Type, 2018-2029 (USD Million) |
|
|
10.3.11.3. Italy
Molecular Diagnostics Market, By Technology, 2018-2029 (USD Million) |
|
|
10.3.11.4. Italy Molecular
Diagnostics Market, By Application, 2018-2029 (USD Million) |
|
|
10.3.11.5. Italy
Molecular Diagnostics Market, By End User, 2018-2029 (USD Million) |
|
|
10.3.12. Rest of Europe |
|
|
10.3.12.1. Rest
of Europe Molecular Diagnostics Market, By Product & Service, 2018-2029
(USD Million) |
|
|
10.3.12.2. Rest
of Europe Molecular Diagnostics Market, By Test Type, 2018-2029 (USD Million) |
|
|
10.3.12.3. Rest
of Europe Molecular Diagnostics Market, By Technology, 2018-2029 (USD
Million) |
|
|
10.3.12.4. Rest
of Europe Molecular Diagnostics Market, By Application, 2018-2029 (USD
Million) |
|
|
10.3.12.5. Rest
of Europe Molecular Diagnostics Market, By End User, 2018-2029 (USD Million) |
|
|
10.4. Asia Pacific |
|
|
10.4.1. Asia Pacific Molecular
Diagnostics Market, By Product & Service, 2018-2029 (USD Million) |
|
|
10.4.2. Asia Pacific Molecular
Diagnostics Market, By Test Type, 2018-2029 (USD Million) |
|
|
10.4.3. Asia Pacific Molecular
Diagnostics Market, By Technology, 2018-2029 (USD Million) |
|
|
10.4.4. Asia Pacific Molecular
Diagnostics Market, By Application, 2018-2029 (USD Million) |
|
|
10.5.5. Asia Pacific Molecular
Diagnostics Market, By End User, 2018-2029 (USD Million) |
|
|
10.4.6. Asia Pacific Molecular
Diagnostics Market, By Country, 2018-2029 (USD Million) |
|
|
10.4.7. India |
|
|
10.4.7.1. India
Molecular Diagnostics Market, By Product & Service, 2018-2029 (USD
Million) |
|
|
10.4.7.2. India
Molecular Diagnostics Market, By Test Type, 2018-2029 (USD Million) |
|
|
10.4.7.3. India
Molecular Diagnostics Market, By Technology, 2018-2029 (USD Million) |
|
|
10.4.7.4. India
Molecular Diagnostics Market, By Application, 2018-2029 (USD Million) |
|
|
10.5.7.5. India
Molecular Diagnostics Market, By End User, 2018-2029 (USD Million) |
|
|
10.4.8. Japan |
|
|
10.4.8.1. Japan
Molecular Diagnostics Market, By Product & Service, 2017-2029 (USD
Million) |
|
|
10.4.8.2. Japan
Molecular Diagnostics Market, By Test Type, 2017-2029 (USD Million) |
|
|
10.4.8.3. Japan
Molecular Diagnostics Market, By Technology, 2017-2029 (USD Million) |
|
|
10.4.8.4. Japan
Molecular Diagnostics Market, By Application, 2017-2029 (USD Million) |
|
|
10.5.8.5. Japan Molecular
Diagnostics Market, By End User, 2017-2029 (USD Million) |
|
|
10.4.9. China |
|
|
10.4.9.1. China
Molecular Diagnostics Market, By Product & Service, 2019-2029 (USD
Million) |
|
|
10.4.9.2. China
Molecular Diagnostics Market, By Test Type, 2019-2029 (USD Million) |
|
|
10.4.9.3. China
Molecular Diagnostics Market, By Technology, 2019-2029 (USD Million) |
|
|
10.4.9.4. China Molecular
Diagnostics Market, By Application, 2019-2029 (USD Million) |
|
|
10.5.10.5. China
Molecular Diagnostics Market, By End User, 2019-2029 (USD Million) |
|
|
10.4.10. South Korea |
|
|
10.4.10.1. South
Korea Molecular Diagnostics Market, By Product & Service, 2018-2029 (USD
Million) |
|
|
10.4.10.2. South
Korea Molecular Diagnostics Market, By Test Type, 2018-2029 (USD Million) |
|
|
10.4.10.3. South
Korea Molecular Diagnostics Market, By Technology, 2018-2029 (USD Million) |
|
|
10.4.10.4. South
Korea Molecular Diagnostics Market, By Application, 2018-2029 (USD Million) |
|
|
10.5.10.5. South Korea
Molecular Diagnostics Market, By End User, 2018-2029 (USD Million) |
|
|
10.4.11. Australia |
|
|
10.4.11.1.
Australia Molecular Diagnostics Market, By Product & Service, 2018-2029
(USD Million) |
|
|
10.4.11.2. Australia Molecular
Diagnostics Market, By Test Type, 2018-2029 (USD Million) |
|
|
10.4.11.3. Australia
Molecular Diagnostics Market, By Technology, 2018-2029 (USD Million) |
|
|
10.4.11.4.
Australia Molecular Diagnostics Market, By Application, 2018-2029 (USD
Million) |
|
|
10.5.11.5.
Australia Molecular Diagnostics Market, By End User, 2018-2029 (USD Million) |
|
|
10.4.12. Rest of Asia Pacific |
|
|
10.4.12.1. Rest
of Asia Pacific Molecular Diagnostics Market, By Product & Service,
2018-2029 (USD Million) |
|
|
10.4.12.2. Rest of Asia
Pacific Molecular Diagnostics Market, By Test Type, 2018-2029 (USD Million) |
|
|
10.4.12.3. Rest
of Asia Pacific Molecular Diagnostics Market, By Technology, 2018-2029 (USD
Million) |
|
|
10.4.12.4. Rest of
Asia Pacific Molecular Diagnostics Market, By Application, 2018-2029 (USD
Million) |
|
|
10.5.12.5. Rest
of Asia Pacific Molecular Diagnostics Market, By End User, 2018-2029 (USD
Million) |
|
|
10.5. Middle East & Africa |
|
|
10.5.1. Middle East &
Africa Molecular Diagnostics Market, By Product & Service, 2018-2029 (USD
Million) |
|
|
10.5.2. Middle East & AfricaMolecular
Diagnostics Market, By Test Type, 2018-2029 (USD Million) |
|
|
10.5.3. Middle East &
Africa Molecular Diagnostics Market, By Technology, 2018-2029 (USD Million) |
|
|
10.5.4. Middle East &
Africa Molecular Diagnostics Market, By Application, 2018-2029 (USD Million) |
|
|
10.5.5. Middle East &
Africa Molecular Diagnostics Market, By End User, 2018-2029 (USD Million) |
|
|
10.5.6. Middle East &
Africa Molecular Diagnostics Market, By Country, 2018-2029 (USD Million) |
|
|
10.5.7. UAE |
|
|
10.5.7.1. UAE
Molecular Diagnostics Market, By Product & Service, 2018-2029 (USD
Million) |
|
|
10.5.7.2. UAE Molecular
Diagnostics Market, By Test Type, 2018-2029 (USD Million) |
|
|
10.5.7.3. UAE
Molecular Diagnostics Market, By Technology, 2018-2029 (USD Million) |
|
|
10.5.7.4. UAE
Molecular Diagnostics Market, By Application, 2018-2029 (USD Million) |
|
|
10.5.7.5. UAE
Molecular Diagnostics Market, By End User, 2018-2029 (USD Million) |
|
|
10.5.8. Saudi Arabia |
|
|
10.5.8.1. Saudi
Arabia Molecular Diagnostics Market, By Product & Service, 2017-2029 (USD
Million) |
|
|
10.5.8.2. Saudi
Arabia Molecular Diagnostics Market, By Test Type, 2017-2029 (USD Million) |
|
|
10.5.8.3. Saudi Arabia
Molecular Diagnostics Market, By Technology, 2017-2029 (USD Million) |
|
|
10.5.8.4. Saudi
Arabia Molecular Diagnostics Market, By Application, 2017-2029 (USD Million) |
|
|
10.5.8.5. Saudi
Arabia Molecular Diagnostics Market, By End User, 2017-2029 (USD Million) |
|
|
10.5.9. South Africa |
|
|
10.5.9.1. South
Africa Molecular Diagnostics Market, By Product & Service, 2019-2029 (USD
Million) |
|
|
10.5.9.2. South Africa Molecular
Diagnostics Market, By Test Type, 2019-2029 (USD Million) |
|
|
10.5.9.3. South
Africa Molecular Diagnostics Market, By Technology, 2019-2029 (USD Million) |
|
|
10.5.9.4. South
Africa Molecular Diagnostics Market, By Application, 2019-2029 (USD Million) |
|
|
10.5.9.5. South
Africa Molecular Diagnostics Market, By End User, 2019-2029 (USD Million) |
|
|
10.5.10. Rest of Middle East
& Africa |
|
|
10.5.10.1. Rest
of Middle East & Africa Molecular Diagnostics Market, By Product &
Service, 2018-2029 (USD Million) |
|
|
10.5.10.2. Rest of
Middle East & Africa Molecular Diagnostics Market, By Test Type,
2018-2029 (USD Million) |
|
|
10.5.10.3. Rest
of Middle East & Africa Molecular Diagnostics Market, By Technology,
2018-2029 (USD Million) |
|
|
10.5.10.4. Rest of Middle East &
Africa Molecular Diagnostics Market, By Application, 2018-2029 (USD Million) |
|
|
10.5.10.5. Rest
of Middle East & Africa Molecular Diagnostics Market, By End User,
2018-2029 (USD Million) |
|
|
10.6. Latin America |
|
|
10.6.1. Latin America Molecular
Diagnostics Market, By Product & Service, 2018-2029 (USD Million) |
|
|
10.6.2. Latin America Molecular
Diagnostics Market, By Test Type, 2018-2029 (USD Million) |
|
|
10.6.3. Latin America Molecular
Diagnostics Market, By Technology, 2018-2029 (USD Million) |
|
|
10.6.4. Latin America Molecular
Diagnostics Market, By Application, 2018-2029 (USD Million) |
|
|
10.6.5. Latin America Molecular
Diagnostics Market, By End User, 2018-2029 (USD Million) |
|
|
10.6.6. Latin America Molecular
Diagnostics Market, By Country, 2018-2029 (USD Million) |
|
|
10.6.7. Brazil |
|
|
10.6.7.1. Brazil
Molecular Diagnostics Market, By Product & Service, 2018-2029 (USD
Million) |
|
|
10.6.7.2. Brazil
Molecular Diagnostics Market, By Test Type, 2018-2029 (USD Million) |
|
|
10.6.7.3. Brazil Molecular
Diagnostics Market, By Technology, 2018-2029 (USD Million) |
|
|
10.6.7.4. Brazil
Molecular Diagnostics Market, By Application, 2018-2029 (USD Million) |
|
|
10.6.7.5. Brazil
Molecular Diagnostics Market, By End User, 2018-2029 (USD Million) |
|
|
10.6.8. Mexico |
|
|
10.6.8.1. Mexico
Molecular Diagnostics Market, By Product & Service, 2018-2029 (USD
Million) |
|
|
10.6.8.2. Mexico Molecular Diagnostics
Market, By Test Type, 2018-2029 (USD Million) |
|
|
10.6.8.3. Mexico
Molecular Diagnostics Market, By Technology, 2018-2029 (USD Million) |
|
|
10.6.8.4. Mexico
Molecular Diagnostics Market, By Application, 2018-2029 (USD Million) |
|
|
10.6.8.5. Mexico
Molecular Diagnostics Market, By End User, 2018-2029 (USD Million) |
|
|
10.6.9. Argentina |
|
|
10.6.9.1.
Argentina Molecular Diagnostics Market, By Product & Service, 2019-2029
(USD Million) |
|
|
10.6.9.2.
Argentina Molecular Diagnostics Market, By Test Type, 2019-2029 (USD Million) |
|
|
10.6.9.3. Argentina
Molecular Diagnostics Market, By Technology, 2019-2029 (USD Million) |
|
|
10.6.9.4.
Argentina Molecular Diagnostics Market, By Application, 2019-2029 (USD
Million) |
|
|
10.6.9.5.
Argentina Molecular Diagnostics Market, By End User, 2019-2029 (USD Million) |
|
|
10.6.10. Rest of Latin America |
|
|
10.6.10.1. Rest
of Latin America Molecular Diagnostics Market, By Product & Service,
2018-2029 (USD Million) |
|
|
10.6.10.2. Rest of Latin
America Molecular Diagnostics Market, By Test Type, 2018-2029 (USD Million) |
|
|
10.6.10.3. Rest of
Latin America Molecular Diagnostics Market, By Technology, 2018-2029 (USD
Million) |
|
|
10.6.10.4. Rest
of Latin America Molecular Diagnostics Market, By Application, 2018-2029 (USD
Million) |
|
|
10.6.10.5. Rest
of Latin America Molecular Diagnostics Market, By End User, 2018-2029 (USD
Million) |
|
|
Chapter 11. Competitive Landscape |
|
|
11.1. Market Revenue Share by
Manufacturers |
|
|
11.2. Competitor’s Positioning |
|
|
11.3. Strategy Benchmarking |
|
|
11.3.1. Partnership &
Agreement |
|
|
11.3.2. New Product
Development |
|
|
11.3.3. Mergers &
Acquisitions |
|
|
11.3.4. Investment &
Expansion |
|
|
11.4. Vendor Landscape |
|
|
11.4.1. Distributors |
|
|
11.4.2. North America |
|
|
11.4.3. Europe |
|
|
11.4.4. Asia Pacific |
|
|
11.4.5. Middle East &
Africa |
|
|
11.4.6. Latin America |
|
|
11.5. Zettabyte Analytics Insights for
Competitive Landscape |
|
|
Chapter 12. Company
Profiles |
|
|
12.1. Abacus Diagnostica Oy |
|
|
12.1.1. Company Overview |
|
|
12.1.2. Products Offered |
|
|
12.1.3. Financials |
|
|
12.1.4. Recent Development |
|
|
12.2. Abbott Laboratories |
|
|
12.2.1. Company Overview |
|
|
12.2.2. Products Offered |
|
|
12.2.3. Financials |
|
|
12.2.4. Recent
Development |
|
|
12.3. Agilent Technologies, Inc. |
|
|
12.3.1. Company Overview |
|
|
12.3.2. Products Offered |
|
|
12.3.3. Financials |
|
|
12.3.4. Recent
Development |
|
|
12.4. Amoy Diagnostics Co., Ltd. |
|
|
12.4.1. Company Overview |
|
|
12.4.2. Products Offered |
|
|
12.4.3. Financials |
|
|
12.4.4. Recent
Development |
|
|
12.5. Becton, Dickinson And Company |
|
|
12.5.1. Company Overview |
|
|
12.5.2. Products Offered |
|
|
12.5.3. Financials |
|
|
12.5.4. Recent
Development |
|
|
12.6. Biocartis Nv |
|
|
12.6.1. Company Overview |
|
|
12.6.2. Products Offered |
|
|
12.6.3. Financials |
|
|
12.6.4. Recent
Development |
|
|
12.7. Biomérieux Sa |
|
|
12.7.1. Company Overview |
|
|
12.7.2. Products Offered |
|
|
12.7.3. Financials |
|
|
12.7.4. Recent
Development |
|
|
12.8. Danaher Corporation |
|
|
12.8.1. Company Overview |
|
|
12.8.2. Products Offered |
|
|
12.8.3. Financials |
|
|
12.8.4. Recent
Development |
|
|
12.9. Diasorin S.P.A. |
|
|
12.9.1. Company Overview |
|
|
12.9.2. Products Offered |
|
|
12.9.3. Financials |
|
|
12.9.4. Recent
Development |
|
|
12.10. Elitechgroup |
|
|
12.10.1. Company Overview |
|
|
12.10.2. Products Offered |
|
|
12.10.3. Financials |
|
|
12.10.4. Recent
Development |
|
|
12.11. Exact Sciences Corporation |
|
|
12.11.1. Company Overview |
|
|
12.11.2. Products Offered |
|
|
12.11.3. Financials |
|
|
12.11.4. Recent
Development |
|
|
12.12. F. Hoffmann-La Roche Ltd |
|
|
12.12.1. Company Overview |
|
|
12.12.2. Products Offered |
|
|
12.12.3. Financials |
|
|
12.12.4. Recent
Development |
|
|
12.13. Geneombio Technologies Pvt. Ltd. |
|
|
12.13.1. Company Overview |
|
|
12.13.2. Products Offered |
|
|
12.13.3. Financials |
|
|
12.13.4. Recent
Development |
|
|
12.14. Genetic Signatures |
|
|
12.14.1. Company Overview |
|
|
12.14.2. Products Offered |
|
|
12.14.3. Financials |
|
|
12.14.4. Recent
Development |
|
|
12.15. Grifols, S.A. |
|
|
12.15.1. Company Overview |
|
|
12.15.2. Products Offered |
|
|
12.15.3. Financials |
|
|
12.15.4. Recent Development |
|
|
12.16. Hologic, Inc. |
|
|
12.16.1. Company Overview |
|
|
12.16.2. Products Offered |
|
|
12.16.3. Financials |
|
|
12.16.4. Recent
Development |
|
|
12.17. Htg Molecular Diagnostics, Inc. |
|
|
12.17.1. Company Overview |
|
|
12.17.2. Products Offered |
|
|
12.17.3. Financials |
|
|
12.17.4. Recent
Development |
|
|
12.18. Illumina, Inc. |
|
|
12.18.1. Company Overview |
|
|
12.18.2. Products Offered |
|
|
12.18.3. Financials |
|
|
12.18.4. Recent
Development |
|
|
12.19. Mdxhealth |
|
|
12.19.1. Company Overview |
|
|
12.19.2. Products Offered |
|
|
12.19.3. Financials |
|
|
12.19.4. Recent
Development |
|
|
12.20. Molbio Diagnostics Pvt. Ltd. |
|
|
12.20.1. Company Overview |
|
|
12.20.2. Products Offered |
|
|
12.20.3. Financials |
|
|
12.20.4. Recent
Development |
|
|
12.21. Myriad Genetics, Inc. |
|
|
12.21.1. Company Overview |
|
|
12.21.2. Products Offered |
|
|
12.21.3. Financials |
|
|
12.21.4. Recent
Development |
|
|
12.22. Perkinelmer, Inc. |
|
|
12.22.1. Company Overview |
|
|
12.22.2. Products Offered |
|
|
12.22.3. Financials |
|
|
12.22.4. Recent
Development |
|
|
12.23. Qiagen N.V. |
|
|
12.23.1. Company Overview |
|
|
12.23.2. Products Offered |
|
|
12.23.3. Financials |
|
|
12.23.4. Recent
Development |
|
|
12.24. Quidel Corporation |
|
|
12.24.1. Company Overview |
|
|
12.24.2. Products Offered |
|
|
12.24.3. Financials |
|
|
12.24.4. Recent
Development |
|
|
12.25. Savyon Diagnostics |
|
|
12.25.1. Company Overview |
|
|
12.25.2. Products Offered |
|
|
12.25.3. Financials |
|
|
12.25.4. Recent
Development |
|
|
12.26. Siemens Healthineers Ag |
|
|
12.26.1. Company Overview |
|
|
12.26.2. Products Offered |
|
|
12.26.3. Financials |
|
|
12.26.4. Recent
Development |
|
|
12.27. Tbg Diagnostics Limited |
|
|
12.27.1. Company Overview |
|
|
12.27.2. Products Offered |
|
|
12.27.3. Financials |
|
|
12.27.4. Recent
Development |
|
|
12.28. Thermo Fisher Scientific, Inc. |
|
|
12.28.1. Company Overview |
|
|
12.28.2. Products Offered |
|
|
12.28.3. Financials |
|
|
12.28.4. Recent
Development |
|
|
12.29. Vela Diagnostics |
|
|
12.29.1. Company Overview |
|
|
12.29.2. Products Offered |
|
|
12.29.3. Financials |
|
|
12.29.4. Recent
Development |
|
|
Chapter 12. Research
Methodology |
|
|
12.1. Research Sources |
|
|
12.1.1. Primary |
|
|
12.1.2. Secondary |
|
|
12.12. Market Size Estimation |
|
|
Chapter 13. Appendix |
|
|
13.1. Discussion guide |
|
|
13.2. Knowledge Store:
Zettabyte Analytics Subscription Portal |
|
|
13.3. Available
Customizations |
|
|
13.4. Associated
Zettabyte Analytics Reports |
|
|
List of Tables |
|
|
Table 1 |
Molecular Diagnostics
Market, By Product & Service (Market Size and Forecast by Value - USD
Million, 2021 & 2029) |
|
Table 2 |
Reagents & Kits
Market Estimates and Forecast, 2019-2029 (USD Million) |
|
Table 3 |
Reagents & Kits
Market Estimates and Forecast, By Region, 2019-2029 (USD Million) |
|
Table 4 |
Instruments Market
Estimates and Forecast, 2019-2029 (USD Million) |
|
Table 5 |
Instruments Market
Estimates and Forecast, By Region, 2019-2029 (USD Million) |
|
Table 6 |
Molecular Diagnostics
Market, By Test Type (Market Size and Forecast by Value - USD Million, 2021 &
2029) |
|
Table 7 |
Lab Tests Market
Estimates and Forecast, 2019-2029 (USD Million) |
|
Table 8 |
Lab Tests Market
Estimates and Forecast, By Region, 2019-2029 (USD Million) |
|
Table 9 |
Molecular Diagnostics
Market, By Technology (Market Size and Forecast by Value - USD Million, 2021
& 2029) |
|
Table 10 |
Polymerase Chain Reaction
(PCR) Market Estimates and Forecast, 2019-2029 (USD Million) |
|
Table 11 |
Polymerase Chain Reaction
(PCR) Market Estimates and Forecast, By Region, 2019-2029 (USD Million) |
|
Table 12 |
Isothermal Nucleic Acid
Amplification Technology (INAAT) Market Estimates and Forecast, 2019-2029
(USD Million) |
|
Table 13 |
Isothermal Nucleic Acid
Amplification Technology (INAAT) Market Estimates and Forecast, By Region,
2019-2029 (USD Million) |
|
Table 14 |
DNA Sequencing &
Next- generation Sequencing (NGS) Market Estimates and Forecast, 2019-2029
(USD Million) |
|
Table 15 |
DNA Sequencing &
Next- generation Sequencing (NGS) Market Estimates and Forecast, By Region,
2019-2029 (USD Million) |
|
Table 16 |
Molecular Diagnostics
Market, By Application (Market Size and Forecast by Value - USD Million, 2021
& 2029) |
|
Table 17 |
Infectious Disease
Diagnostics Market Estimates and Forecast, 2019-2029 (USD Million) |
|
Table 18 |
Infectious Disease
Diagnostics Market Estimates and Forecast, By Region, 2019-2029 (USD Million) |
|
Table 19 |
Oncology Testing Market
Estimates and Forecast, 2019-2029 (USD Million) |
|
Table 20 |
Oncology Testing Market
Estimates and Forecast, By Region, 2019-2029 (USD Million) |
|
Table 21 |
North America Molecular
Diagnostics Market, By Product & Service, 2018-2029 (USD Million) |
|
Table 22 |
North America Molecular
Diagnostics Market, By Test Type, 2018-2029 (USD Million) |
|
Table 23 |
North America Molecular
Diagnostics Market, By Technology, 2018-2029 (USD Million) |
|
Table 24 |
North America Molecular
Diagnostics Market, By Application, 2018-2029 (USD Million) |
|
Table 25 |
North America Molecular
Diagnostics Market, By Country, 2018-2029 (USD Million) |
|
Table 26 |
U.S. Molecular
Diagnostics Market, By Product & Service, 2018-2029 (USD Million) |
|
Table 27 |
U.S. Molecular
Diagnostics Market, By Test Type, 2018-2029 (USD Million) |
|
Table 28 |
U.S. Molecular
Diagnostics Market, By Technology, 2018-2029 (USD Million) |
|
Table 29 |
U.S. Molecular
Diagnostics Market, By Application, 2018-2029 (USD Million) |
|
Table 30 |
Canada Molecular
Diagnostics Market, By Product & Service, 2018-2029 (USD Million) |
|
Table 31 |
Canada Molecular
Diagnostics Market, By Test Type, 2018-2029 (USD Million) |
|
Table 32 |
Canada Molecular
Diagnostics Market, By Technology, 2018-2029 (USD Million) |
|
Table 33 |
Canada Molecular
Diagnostics Market, By Application, 2018-2029 (USD Million) |
|
Table 34 |
Europe Molecular
Diagnostics Market, By Product & Service, 2018-2029 (USD Million) |
|
Table 35 |
Europe Molecular
Diagnostics Market, By Test Type, 2018-2029 (USD Million) |
|
Table 36 |
Europe Molecular
Diagnostics Market, By Technology, 2018-2029 (USD Million) |
|
Table 37 |
EuropeMolecular
Diagnostics Market, By Application, 2018-2029 (USD Million) |
|
Table 38 |
Europe Molecular
Diagnostics Market, By Country, 2018-2029 (USD Million) |
|
Table 39 |
Germany Molecular
Diagnostics Market, By Product & Service, 2018-2029 (USD Million) |
|
Table 40 |
Germany Molecular
Diagnostics Market, By Test Type, 2018-2029 (USD Million) |
|
Table 41 |
Germany Molecular
Diagnostics Market, By Technology, 2018-2029 (USD Million) |
|
Table 42 |
Germany Molecular
Diagnostics Market, By Application, 2018-2029 (USD Million) |
|
Table 43 |
U.K. Molecular
Diagnostics Market, By Product & Service, 2018-2029 (USD Million) |
|
Table 44 |
U.K. Molecular
Diagnostics Market, By Test Type, 2018-2029 (USD Million) |
|
Table 45 |
U.K. Molecular
Diagnostics Market, By Technology, 2018-2029 (USD Million) |
|
Table 46 |
U.K. Molecular
Diagnostics Market, By Application, 2018-2029 (USD Million) |
|
Table 47 |
France Molecular
Diagnostics Market, By Product & Service, 2018-2029 (USD Million) |
|
Table 48 |
France Molecular
Diagnostics Market, By Test Type, 2018-2029 (USD Million) |
|
Table 49 |
France Molecular
Diagnostics Market, By Technology, 2018-2029 (USD Million) |
|
Table 50 |
France Molecular
Diagnostics Market, By Application, 2018-2029 (USD Million) |
|
Table 51 |
Spain Molecular
Diagnostics Market, By Product & Service, 2018-2029 (USD Million) |
|
Table 52 |
Spain Molecular
Diagnostics Market, By Test Type, 2018-2029 (USD Million) |
|
Table 53 |
Spain Molecular
Diagnostics Market, By Technology, 2018-2029 (USD Million) |
|
Table 54 |
Spain Molecular
Diagnostics Market, By Application, 2018-2029 (USD Million) |
|
Table 55 |
Italy Molecular
Diagnostics Market, By Product & Service, 2018-2029 (USD Million) |
|
Table 56 |
Italy Molecular
Diagnostics Market, By Test Type, 2018-2029 (USD Million) |
|
Table 57 |
Italy Molecular
Diagnostics Market, By Technology, 2018-2029 (USD Million) |
|
Table 58 |
Italy Molecular
Diagnostics Market, By Application, 2018-2029 (USD Million) |
|
Table 59 |
Rest of Europe Molecular
Diagnostics Market, By Product & Service, 2018-2029 (USD Million) |
|
Table 60 |
Rest of Europe Molecular
Diagnostics Market, By Test Type, 2018-2029 (USD Million) |
|
Table 61 |
Rest of Europe Molecular
Diagnostics Market, By Technology, 2018-2029 (USD Million) |
|
Table 62 |
Rest of Europe Molecular
Diagnostics Market, By Application, 2018-2029 (USD Million) |
|
Table 63 |
Asia Pacific Molecular
Diagnostics Market, By Product & Service, 2018-2029 (USD Million) |
|
Table 64 |
Asia Pacific Molecular
Diagnostics Market, By Test Type, 2018-2029 (USD Million) |
|
Table 65 |
Asia Pacific Molecular
Diagnostics Market, By Technology, 2018-2029 (USD Million) |
|
Table 66 |
Asia Pacific Molecular
Diagnostics Market, By Application, 2018-2029 (USD Million) |
|
Table 67 |
Asia Pacific Molecular
Diagnostics Market, By Country, 2018-2029 (USD Million) |
|
Table 68 |
India Molecular
Diagnostics Market, By Product & Service, 2018-2029 (USD Million) |
|
Table 69 |
India Molecular
Diagnostics Market, By Test Type, 2018-2029 (USD Million) |
|
Table 70 |
India Molecular
Diagnostics Market, By Technology, 2018-2029 (USD Million) |
|
Table 71 |
India Molecular
Diagnostics Market, By Application, 2018-2029 (USD Million) |
|
Table 72 |
Japan Molecular
Diagnostics Market, By Product & Service, 2018-2029 (USD Million) |
|
Table 73 |
Japan Molecular
Diagnostics Market, By Test Type, 2018-2029 (USD Million) |
|
Table 74 |
Japan Molecular
Diagnostics Market, By Technology, 2018-2029 (USD Million) |
|
Table 75 |
Japan Molecular
Diagnostics Market, By Application, 2018-2029 (USD Million) |
|
Table 76 |
China Molecular
Diagnostics Market, By Product & Service, 2018-2029 (USD Million) |
|
Table 77 |
China Molecular
Diagnostics Market, By Test Type, 2018-2029 (USD Million) |
|
Table 78 |
China Molecular
Diagnostics Market, By Technology, 2018-2029 (USD Million) |
|
Table 79 |
China Molecular
Diagnostics Market, By Application, 2018-2029 (USD Million) |
|
Table 80 |
South Korea Molecular
Diagnostics Market, By Product & Service, 2018-2029 (USD Million) |
|
Table 81 |
South Korea Molecular
Diagnostics Market, By Test Type, 2018-2029 (USD Million) |
|
Table 82 |
South Korea Molecular
Diagnostics Market, By Technology, 2018-2029 (USD Million) |
|
Table 83 |
South Korea Molecular
Diagnostics Market, By Application, 2018-2029 (USD Million) |
|
Table 84 |
Australia Molecular
Diagnostics Market, By Product & Service, 2018-2029 (USD Million) |
|
Table 85 |
Australia Molecular
Diagnostics Market, By Test Type, 2018-2029 (USD Million) |
|
Table 86 |
Australia Molecular
Diagnostics Market, By Technology, 2018-2029 (USD Million) |
|
Table 87 |
Australia Molecular
Diagnostics Market, By Application, 2018-2029 (USD Million) |
|
Table 88 |
Rest of Asia Pacific
Molecular Diagnostics Market, By Product & Service, 2018-2029 (USD
Million) |
|
Table 89 |
Rest of Asia Pacific
Molecular Diagnostics Market, By Test Type, 2018-2029 (USD Million) |
|
Table 90 |
Rest of Asia Pacific
Molecular Diagnostics Market, By Technology, 2018-2029 (USD Million) |
|
Table 91 |
Rest of Asia Pacific
Molecular Diagnostics Market, By Application, 2018-2029 (USD Million) |
|
Table 92 |
Middle East & Africa
Molecular Diagnostics Market, By Product & Service, 2018-2029 (USD
Million) |
|
Table 93 |
Middle East &
AfricaMolecular Diagnostics Market, By Test Type, 2018-2029 (USD Million) |
|
Table 94 |
Middle East & Africa
Molecular Diagnostics Market, By Technology, 2018-2029 (USD Million) |
|
Table 95 |
Middle East & Africa
Molecular Diagnostics Market, By Application, 2018-2029 (USD Million) |
|
Table 96 |
Middle East & Africa
Molecular Diagnostics Market, By Country, 2018-2029 (USD Million) |
|
Table 97 |
UAE Molecular Diagnostics
Market, By Product & Service, 2018-2029 (USD Million) |
|
Table 98 |
UAE Molecular Diagnostics
Market, By Test Type, 2018-2029 (USD Million) |
|
Table 99 |
UAE Molecular Diagnostics
Market, By Technology, 2018-2029 (USD Million) |
|
Table 100 |
UAE Molecular Diagnostics
Market, By Application, 2018-2029 (USD Million) |
|
Table 101 |
Saudi Arabia Molecular
Diagnostics Market, By Product & Service, 2018-2029 (USD Million) |
|
Table 102 |
Saudi Arabia Molecular
Diagnostics Market, By Test Type, 2018-2029 (USD Million) |
|
Table 103 |
Saudi Arabia Molecular
Diagnostics Market, By Technology, 2018-2029 (USD Million) |
|
Table 104 |
Saudi Arabia Molecular
Diagnostics Market, By Application, 2018-2029 (USD Million) |
|
Table 105 |
South Africa Molecular
Diagnostics Market, By Product & Service, 2018-2029 (USD Million) |
|
Table 106 |
South Africa Molecular
Diagnostics Market, By Test Type, 2018-2029 (USD Million) |
|
Table 107 |
South Africa Molecular
Diagnostics Market, By Technology, 2018-2029 (USD Million) |
|
Table 108 |
South Africa Molecular
Diagnostics Market, By Application, 2018-2029 (USD Million) |
|
Table 109 |
Rest of Middle East &
Africa Molecular Diagnostics Market, By Product & Service, 2018-2029 (USD
Million) |
|
Table 110 |
Rest of Middle East &
Africa Molecular Diagnostics Market, By Test Type, 2018-2029 (USD Million) |
|
Table 111 |
Rest of Middle East &
Africa Molecular Diagnostics Market, By Technology, 2018-2029 (USD Million) |
|
Table 112 |
Rest of Middle East &
Africa Molecular Diagnostics Market, By Application, 2018-2029 (USD Million) |
|
Table 113 |
Latin America Molecular
Diagnostics Market, By Product & Service, 2018-2029 (USD Million) |
|
Table 114 |
Latin America Molecular
Diagnostics Market, By Test Type, 2018-2029 (USD Million) |
|
Table 115 |
Latin America Molecular
Diagnostics Market, By Technology, 2018-2029 (USD Million) |
|
Table 116 |
Latin America Molecular
Diagnostics Market, By Application, 2018-2029 (USD Million) |
|
Table 117 |
Latin America Molecular
Diagnostics Market, By Country, 2018-2029 (USD Million) |
|
Table 118 |
Brazil Molecular
Diagnostics Market, By Product & Service, 2018-2029 (USD Million) |
|
Table 119 |
Brazil Molecular
Diagnostics Market, By Test Type, 2018-2029 (USD Million) |
|
Table 120 |
Brazil Molecular
Diagnostics Market, By Technology, 2018-2029 (USD Million) |
|
Table 121 |
Brazil Molecular
Diagnostics Market, By Application, 2018-2029 (USD Million) |
|
Table 122 |
Mexico Molecular
Diagnostics Market, By Product & Service, 2018-2029 (USD Million) |
|
Table 123 |
Mexico Molecular
Diagnostics Market, By Test Type, 2018-2029 (USD Million) |
|
Table 124 |
Mexico Molecular
Diagnostics Market, By Technology, 2018-2029 (USD Million) |
|
Table 125 |
Mexico Molecular
Diagnostics Market, By Application, 2018-2029 (USD Million) |
|
Table 126 |
Argentina Molecular
Diagnostics Market, By Product & Service, 2018-2029 (USD Million) |
|
Table 127 |
Argentina Molecular
Diagnostics Market, By Test Type, 2018-2029 (USD Million) |
|
Table 128 |
Argentina Molecular
Diagnostics Market, By Technology, 2018-2029 (USD Million) |
|
Table 129 |
Argentina Molecular
Diagnostics Market, By Application, 2018-2029 (USD Million) |
|
Table 130 |
Rest of Latin America
Molecular Diagnostics Market, By Product & Service, 2018-2029 (USD
Million) |
|
Table 131 |
Rest of Latin America
Molecular Diagnostics Market, By Test Type, 2018-2029 (USD Million) |
|
Table 132 |
Rest of Latin America
Molecular Diagnostics Market, By Technology, 2018-2029 (USD Million) |
|
Table 133 |
Rest of Latin America
Molecular Diagnostics Market, By Application, 2018-2029 (USD Million) |
|
Table 134 |
Product Launch &
Development in The Molecular Diagnostics Market, 2018-2021 |
|
Table 135 |
Investment and Expansion
in The Molecular Diagnostics Market, 2018-2021 |
|
Table 136 |
Partnership &
Collaboration in The Molecular Diagnostics Market, 2018-2021 |
|
Table 137 |
Merger & Acquisition
in The Molecular Diagnostics Market, 2018-2021 |
|
List of Figures |
|
|
Figure 1 |
Research Methodology |
|
Figure 2 |
Summary Snapshot Market
Size and Forecast, USD Million, 2021 & 2029 |
|
Figure 3 |
Global Molecular
Diagnostics Market Segmentation & Impact Analysis |
|
Figure 4 |
Regulatory Analysis |
|
Figure 5 |
COVID-19 Impact analysis
on Molecular Diagnostics Market |
|
Figure 6 |
Market Revenue Share by
Manufacturers |
|
Figure 7 |
Molecular Diagnostics
Market, By Product & Service (Market Size and Forecast by Value - USD
Million, 2021 & 2029) |
|
Figure 8 |
Molecular Diagnostics
Market, By Test Type (Market Size and Forecast by Value - USD Million, 2021
& 2029) |
|
Figure 9 |
Molecular Diagnostics
Market, By Technology (Market Size and Forecast by Value - USD Million, 2021
& 2029) |
|
Figure 10 |
Molecular Diagnostics
Market, By Application (Market Size and Forecast by Value - USD Million, 2021
& 2029) |
|
Figure 11 |
Molecular Diagnostics
Market, By Region (Market Size and Forecast by Value - USD Million, 2021
& 2029) |
1.
Research Sources
We at Zettabyte Analytics have a
detailed and related research methodology focussed on estimating the market
size and forecasted value for the given market. Comprehensive research
objectives and scope were obtained through secondary research of the parent and
peer markets. The next step was to validate our research by various market
models and primary research. Both top-down and bottom-up approaches were
employed to estimate the market. In addition to all the research reports, data
triangulation is one of the procedures used to evaluate the market size of
segments and sub-segments.
Research Methodology
1.1. Secondary Research
The secondary research study involves various sources and databases used
to analyze and collect information for the market-oriented survey of a specific
market. We use multiple databases for our exhaustive secondary research, such
as Factiva, Dun & Bradstreet, Bloomberg, Research article, Annual reports,
Press Release, and SEC filings of significant companies. Apart from this, a
dedicated set of teams continuously extracts data of key industry players and
makes an extensive and unique segmentation related to the latest market
development.
1.2. Primary Research
The primary research includes gathering data from specific domain
experts through a detailed questionnaire, emails, telephonic interviews, and
web-based surveys. The primary interviewees for this study include an expert
from the demand and supply side, such as CEOs, VPs, directors, sales heads, and
marketing managers of tire 1,2, and 3 companies across the globe.
1.3. Data Triangulation
The data triangulation is very important for any market study, thus we
at Zettabyte Analytics focus on at least three sources to ensure a high level
of accuracy. The data is triangulated by studying various factors and trends
from both supply and demand side. All the reports published and stored in our
repository follows a detailed process to obtain a reliable insight for our
clients.
1.4. In-House Verification
To validate the segmentation
and verify the data collected, our market expert ensures whether our research
analyst is considering fine distinction before analyzing the market.
1.5. Reporting
In the end,
presenting our research reports complied in a different format for straightforward
valuation such as ppt, pdf, and excel data pack is done.
+1 716 953 3077
sales@zettabyteanalytics.com
109 S Warren St, Syracuse, NY 13202, United States